References
- Long, T.E., Indridason, O.S., Palsson, R. et al. Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study. Blood Cancer J. 12, 133 (2022). https://doi.org/10.1038/s41408-022-00732-3
- Ďurovcová E. Monoklonové gamapatie – laboratórne vyšetrenia v diagnostike a monitorovaní. Newslab, 2016; roč. 7(1): 25–29
- Chen LY, Drayson M, Bunce C, et al. Monoclonal gammopathy of increasing significance: time to screen? Haematologica. 2023 Jun 1;108(6):1476–1486. doi: 10.3324/haematol.2022.281802. PMID: 36373250; PMCID: PMC10233333.
- Leung N, Bridoux F, Batuman V, et al. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group. Nat Rev Nephrol. 2019 Jan;15(1):45–59. doi: 10.1038/s41581-018-0077-4. Erratum in: Nat Rev Nephrol. 2019 Feb;15(2):121. PMID: 30510265; PMCID: PMC7136169.
- Hutchison CA, Batuman V, Behrens J, et al. International Kidney and Monoclonal Gammopathy Research Group. The pathogenesis and diagnosis of acute kidney injury in multiple myeloma. Nat Rev Nephrol. 2011 Nov 1;8(1):43–51. doi: 10.1038/nrneph.2011.168. PMID: 22045243; PMCID: PMC3375610.
- Leung N, Bridoux F, Hutchison CA, et al. International Kidney and Monoclonal Gammopathy Research Group. Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant. Blood. 2012 Nov 22;120(22):4292–5. doi: 10.1182/blood-2012-07-445304. Epub 2012 Oct 9. Review. PubMed PMID: 23047823.
- Yadav P, Sathick IJ, Leung N, et al. Serum free light chain level at diagnosis in myeloma cast nephropathy-a multicentre study. Blood Cancer J. 2020 Mar 3;10(3):28. doi: 10.1038/s41408-020-0295-4. PMID: 32127527; PMCID: PMC7054310.
- Alonso-Titos J, Martínez-Esteban M, López V, et al. Monoclonal gammopathy of renal significance: Early diagnosis is key. Nefrología. Vol. 41. Issue. 5. September – October 2021 pages 489–604. DOI: 10.1016/j.nefroe.2021.11.008
- Kariyawasan C. C, Hughes D.A, Jayatillake M.M, et al. Multiple myeloma: causes and consequences of delay in diagnosis, QJM: An International Journal of Medicine, Volume 100, Issue 10, October 2007, Pages 635–640, https://doi.org/10.1093/qjmed/hcm077
- Dispenzieri A, Kyle RA, Merlini G, et al. International myeloma working group guidelines for serum free light chain analysis in multiple myeloma and related disorders. Leukemia. 2009;23:215–224.
- Frank B, Nelson L, Colin A H, et al. Diagnosis of monoclonal gammopathy of renal significance. Kidney International. Volume 87, Issue 4, 2015, Pages 698–711, ISSN 0085-2538, https://doi.org/10.1038/ki.2014.408.
- Schmidt A. Multiple Myeloma with a Special Focus on Precision Medicine. Healthbook TIMES Oncology Hematology. Vol. 6, Issue 4, 2020. December 07, 2020 CEST. Vol. 6, Issue 4, 2020 December 07
- Yadav P, Leung N, Sanders PW, et al. The use of immunoglobulin light chain assays in the diagnosis of paraprotein-related kidney disease. Kidney Int. 2015 Apr;87(4):692–7. doi: 10.1038/ki.2014.333. Epub 2014 Oct 8. PMID: 25296094; PMCID: PMC4863638.
- Adam Z, Pour L, Harvanová Ľ. Monoklonálne gamapatie klinického významu a další nemoci Grada Publishing, Prague, 2023, p.118–119.
- Castillo JJ, Callander NS, Baljevic M, et al. The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significance. Am J Hematol. 2021 Jul 1;96(7):846–853. doi: 10.1002/ajh.26155. Epub 2021 Mar 25. PMID: 33709474; PMCID: PMC8252623.
- Rajkumar SV. Multiple myeloma: 2020 update on diagnosis, risk-stratification and management. Am J Hematol. 2020 May;95(5):548–567. doi: 10.1002/ajh.25791. Erratum in: Am J Hematol. 2020 Nov;95(11):1444. doi: 10.1002/ajh.25876. PMID: 32212178.
- Motáň V, Vachek J. Diagnostika mnohočetného myelomu: minimum pro nehematology. Acta medicinae. 17/2021